Skip to primary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Post navigation

← Previous Next →

FDA Expands Use of Cystic Fibrosis Medication

Posted on October 5, 2016 by gutsandgrowth

FDA Expands Use of Orkambi ( lumacaftor/ivacaftor)

screen-shot-2016-09-30-at-7-44-33-am

Related blog post:

  • Lumacaftor-Ivacaftor for Cystic Fibrosis | gutsandgrowth

 

Share this:

  • Email a link to a friend (Opens in new window) Email
  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading...

Related

This entry was posted in Pediatrics and tagged cystic fibrosis, Ivacaftor, lumacaftor, Orkambi by gutsandgrowth. Bookmark the permalink.
Blog at WordPress.com.
  • Reblog
  • Subscribe Subscribed
    gutsandgrowth
    Join 1,032 other subscribers

    Have a WordPress.com account? Log in now.

  • gutsandgrowth
    Copy shortlinkView post in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...
%d